Literature DB >> 3897356

Insulin receptors and insulin sensitivity in normo and hyperinsulinemic obese patients.

A Carducci Artenisio, F Ragonese, F Forte, G Saitta, G Perrone, G Lettina, R Campisi, F Consolo.   

Abstract

The authors have studied insulin receptors on peripheral blood monocytes and insulin sensitivity, evaluated by simultaneous infusion of glucose, insulin and somatostatin in 10 control subjects and in 20 obese patients with normal glucose tolerance. The obese patients have been divided into two groups, normo (NO) and hyperinsulinemic (HO), according to the total insulin response during OGTT. We considered HO patients with insulin response higher than M + 2DS of controls. Obese patients showed, in comparison to the controls, a lower specific binding and higher degree of insulin resistance. The subdivision of obese patients allowed us to distinguish two groups. The first was characterized by basal hyperinsulinemia, normal insulin response to the stimulus, reduced number of insulin receptors and normal or slightly reduced sensitivity. The second group showed high basal and after stimulus insulinemic values, reduced number of insulin receptors and high level of insulin resistance. When we compared the two groups of obeses we found that the first has a shorter duration of obesity and lower blood glucose values after OGTT. However both groups show the same reduction of insulin bound and the same degree of basal hyperinsulinemia. These data suggest that a reduction of insulin receptors is not the main factor responsible for insulin resistance in obesity. Furthermore, the presence of basal hyperinsulinemia and normal insulin sensitivity in our first group suggests that the modification of basal insulin concentrations is not dependent on the presence of insulin resistance.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3897356     DOI: 10.1007/bf03348483

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  35 in total

1.  Insulin receptors of skeletal muscle: specific insulin binding sites and demonstration of decreased numbers of sites in obese rats.

Authors:  J Olefsky; V C Bacon; S Baur
Journal:  Metabolism       Date:  1976-02       Impact factor: 8.694

2.  Insulin binding to isolated human adipocytes.

Authors:  J M Olefsky; P Jen; G M Reaven; P Alto
Journal:  Diabetes       Date:  1974-07       Impact factor: 9.461

3.  Insulin-receptor interaction in the obese-hyperglycemic mouse. A model of insulin resistance.

Authors:  C R Kahn; D M Neville; J Roth
Journal:  J Biol Chem       Date:  1973-01-10       Impact factor: 5.157

4.  A one-stage procedure for isolation of granulocytes and lymphocytes from human blood. General sedimentation properties of white blood cells in a 1g gravity field.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

5.  Relationship between in vivo insulin resistance and decreased insulin receptors in obese man.

Authors:  O G Kolterman; G M Reaven; J M Olefsky
Journal:  J Clin Endocrinol Metab       Date:  1979-03       Impact factor: 5.958

6.  Decreased insulin binding to adipocytes and circulating monocytes from obese subjects.

Authors:  J M Olefsky
Journal:  J Clin Invest       Date:  1976-05       Impact factor: 14.808

7.  Longitudinal study on the establishment of insulin resistance in hypothalamic obese mice.

Authors:  Y Le Marchand; P Freychet; B Jeanrenaud
Journal:  Endocrinology       Date:  1978-01       Impact factor: 4.736

8.  Correlation between insulin receptor binding in isolated fat cells and insulin sensitivity in obese human subjects.

Authors:  L C Harrison; F I Martin; R A Melick
Journal:  J Clin Invest       Date:  1976-12       Impact factor: 14.808

9.  Mechanism of the postreceptor defect in insulin action in human obesity. Decrease in glucose transport system activity.

Authors:  T P Ciaraldi; O G Kolterman; J M Olefsky
Journal:  J Clin Invest       Date:  1981-10       Impact factor: 14.808

10.  Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group.

Authors: 
Journal:  Diabetes       Date:  1979-12       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.